Spring 2020 Vol. 10 Issue 01
-
From the Editor-in-Chief
Cancer Epigenetics: Disorganization Drives DysfunctionEmerging insights into epigenetic abnormalities in cancer cells may lead to better cancer outcomes.
by William G. Nelson, MD, PhD
-
Forward Look
Cryoablation May Be a Treatment Option for Some Patients | Getting Help to Avoid Financial Distress | Makers of E-Cigarettes Tout Role in Smoking Cessation | Managing Opioid-Related Constipation | More Options to Prevent Blood Clots in High-Risk Cancer Patients | New Guidelines for Radiation Therapy in Pancreatic Cancer | What’s Next? Spring 2020
-
Your Cancer Guide
Weighing Treatment Options for Advanced CancerPatients with metastatic disease need to carefully consider risks and benefits of therapies within the context of their goals.
by Hester Hill Schnipper
-
Caregiving With Confidence
Strategies for Effective CommunicationWhen families work together to provide care for a loved one, communicating can become a challenge.
by Ashley Jones
-
Policy Matters
Taking Steps to Address Cancer Health DisparitiesCancer outcomes are changing for the better, but advances are not affecting all patients equally.
by Brian Rivers, PhD
-
Can CRISPR Deliver?A gene-editing tool called CRISPR holds promise for treating cancer. What does the new technology mean for patients?
by Stephen Ornes
-
The Puzzle of Pancreatic CancerPancreatic cancer remains a difficult disease to treat and is expected to be the second leading cause of U.S. cancer-related deaths by 2030. Researchers hope clinical trials and insights into the genetics of the disease will reverse the trend.
by Kendall K. Morgan
-
Survivor Profile
A Driving ForceMark Good uses every avenue to spread the news about prostate cancer.
by Lindsey Konkel
-
Advocacy in Action
Leaving a LegacyTwo mothers, each with a son who died of brain cancer, worked together to increase awareness and acceptance of tumor tissue donation.
by Esther Landhuis
-
-
Q&A
A Different MountaintopScience writer Charles Graeber describes how a shift in researchers' understanding of immune function and cancer is leading to effective treatments.
by Marci A. Landsmann
-
Sound Advice
Your Questions, Our AnswersExperts offer advice on getting involved with patient advocacy, expressing feelings to loved ones, and hospice care.
-
Get Involved
Filling a VoidA mother whose son was diagnosed with Burkitt leukemia works to improve access to mental health services for teenagers.
by Elizabeth Rosto Sitko
-
In the Moment – Spring 2020Readers share snapshots of their lives today.
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
